Memento Medicines News and Activities

Acquisition, funding and merger involving Memento Medicines.

• Memento Medicines has just announced a $93 Million fundraising (posted on June 22 2026).

View the org chart displaying its 1 main executives

Most searched biographies at Memento Medicines

• Naveen Daryani, Chief Executive Officer

Create your alert
to follow the executive moves at Memento Medicines.

Memento Medicines has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Memento Medicines

Social media about Memento Medicines

• Memento Medicines on Wikipedia, Google News & Yahoo Finance
• Memento Medicines on LinkedIn, X (Twitter) & YouTube